All Lab Packages Explained

Member Access Required

Already a member? Sign In

Timeline

00:00

Testo chronology labs on the app here. We've enabled people to have access to all the lab panels that I use for my own patients.

03:39

Okay? We have a bunch of panels.

07:21

I'm just making noise. So let's go to the next panel.

11:20

to lump all this stuff together, guys. I spent months on this couple years ago with my attorneys, with my managers fighting for you guys.

14:50

so sensitively affect your, your hypothalamus pituitary with these number. You're not looking at those anymore.

18:07

And I also threw in a lipid panel. You know, they, they make me like throw in like X amount of, of panels together for, for my panel mon, you know, so I was like, s**t, this is awesome for guys, you have to really understand what panel you're, I have all these permutations and combinations and it's got a PSA because when you're on testosterone, you have to look at your prostate, your this is on and Android's monitoring prostate, cholesterol, CB, C, iron studies, of course ferritin.

21:20

Guys, I'm doing it. No one else in the world.

24:53

And then the GGT gamma glutamyl transferase, which is another LFT we check a ST and a LT. But when doctors, nurse practitioners, healthcare providers, and use smart patients that are educated, wanna really see are your LFTs up?

Video Summary

The video explains the structure and purpose of different Testosteronology laboratory packages. It discusses how lab groupings are designed to evaluate hormonal, metabolic, and cardiovascular health. The transcript emphasizes that packages bundle related biomarkers for efficient assessment. It explains why baseline testing differs from follow up testing. The speaker frames lab packages as tools for clinical decision making. This opening section establishes the rationale behind organized testing.

The transcript explains hormone focused packages used to evaluate testosterone and related pathways. It discusses metabolic panels assessing glucose regulation and lipid status. The video highlights cardiovascular markers included to assess overall risk. It explains kidney and liver testing as safety monitoring components. The speaker emphasizes that labs must be interpreted together. This section reinforces comprehensive assessment.

When selection is discussed, the video explains matching lab packages to clinical goals. It emphasizes differences between screening and monitoring panels. The transcript cautions against unnecessary testing without context. It highlights how lab results guide next steps in care. The closing message emphasizes longitudinal tracking. Overall, the video frames lab packages as structured evaluation tools.

Condition Callouts

Hypogonadism

Hypogonadism is a medical condition characterized by inadequate testosterone production. In the transcript, hormone labs are discussed as tools to evaluate hypogonadism.

Metabolic syndrome

Metabolic syndrome is a cluster of metabolic abnormalities including dyslipidemia and insulin resistance. In the transcript, metabolic lab packages are discussed to assess metabolic syndrome risk.

Key Takeaways

Laboratory packages group related biomarkers to assess specific physiological systems.
Hormone focused panels are used to evaluate testosterone related conditions.
Metabolic and cardiovascular packages assess broader health risks discussed in the video.
Kidney and liver labs are included for safety monitoring purposes.
Lab selection should align with clinical goals and monitoring needs.